key: cord-0949498-y336i1kk authors: Staiano, Annamaria; Agostiniani, Rino; Bozzola, Elena; Russo, Rocco; Corsello, Giovanni title: COVID 19 vaccine in the pediatric age: the recommendation of the Italian Pediatric Society date: 2022-03-24 journal: Ital J Pediatr DOI: 10.1186/s13052-022-01244-3 sha: 5c3f6daa15c3a90874412de5c602744b71c6432c doc_id: 949498 cord_uid: y336i1kk Vaccine is an important and effective tool to protect from preventable infectious diseases. Neverthless, in the COVID-19 pandemic era, scientific and accurate information are required to responde to false and misleading information on efficacy and safety of immunization in the pediatric age. Vaccine has been widely considered as an important and effective tool to protect from preventable infectious diseases. Scientific and accurate information are required to get people informed and to contribute avoiding common myths and rumors based on misinformation [1] . The European Pediatric Association, as well as the American Academy of Pediatrics, strongly recommends COVID-19 immunization in 5-11 years old children to reduce the burden of COVID-19, prevent severe COVID-19 disease and avoid neuropsichological consequences of quarantine and isolation among the youngest [2] . The Italian Pediatric Society promote the vaccination in children over 5 years, fighting against false information and unscientific statements and promoting a detailed and accurate answer to families'doubts. The most relevant information to share with the community are reported in the following bulletin. 1. As for COVID-19 vaccine, the most frequent concern from families is on the safeness for children aged 5-11 years [3] . While COVID-19 vaccines were developed rapidly, all steps were taken to make sure they are safe and effectivive for children. During the development of COVID-19 vaccines, phases overlapped to speed up the process, but all phases were completed as required for a clinical trial. COVID-19 vaccine for children ages 5 through 11 years were developed and tested in the same way as adult COVID-19 vaccines. In clinical trial, vaccine side effects were examined and appeared to be mild, similar to those seen with other vaccines recommended in infancy [4] . Data produced by the industry has been reviewed and analysed by Food and Drug Administration in the United States of America, by European Medicines Agency in Europe and Italian Medicines Agency in our Country. So, actually, the vaccine can be considered safe and effective to the target population who will receive it, namely children aged 5-11 years. To enforce this consideration, over 5 milions of children in the world already got one and in some cases two shots, without safety concerns. Over 7 millions of COVID 19 vaccine shot, just 8 myocarditis have been demonstrated correlated to the immunization. All the children had mild symptoms and promptly recovered. Unlike the mild side effects that some may experience after vaccina- [6] . In fact, even children who develop mild symptoms may be affected by sequelae weeks or months after recovering. Getting COVID -19 even if with mild symptoms is not advisable as it does neither guarantee a stronger immunity nor allow a long protection against the virus. It has been demonstrated that people who got an infection maybe re-infected later in life. In children who have had prior symptomatic or asymptomatic SARS-CoV-2 infection, the administration of a single dose of SARS-CoV-2/COVID-19 vaccine may be considered, preferably within 6 months from the infection and no later than 12 months after its resolution. A 2 dose schedule is suggested if the infection happened more than one year before the infection. 4. Finally, children vaccination contribute to stop the spread of COVID-19 in the community and may help protecting those unvaccinable for age or for underlying medical conditions. 5. As for safety concern, one of the mayor doubt is on pubertal development and fertility. There is neither evidence nor plausible scientific base to state that any vaccines, including COVID-19 vaccines, may interfere with puberty and female or male fertility. To date, there is no evidence that vaccine ingredients or antibodies developed following COVID-19 vaccination may interfere with pregnancy. On the contrary, evidence suggested that females who received COVID-19 vaccine met no problems in becoming pregnant [4, 7] . Vaccine hesitancy may interfere with universal children immunization. Answering to families' doubts about vaccine efficacy, safety and real need may represent a winning strategy to promote children immunization. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy Importance of Coronavirus Disease 2019 Vaccination in Children: Viewpoint and Recommendations of the Union of European National Societies of Pediatrics Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot Last access on ISS. Covid 19-Epidemiological report Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years -United States COVID-19 Vaccines in Children and Adolescents. Committee on Infectious Diseases Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Not applicable Authors' contributions AMS planned the manuscript, RA revised literature, EB revised epidemiological data RR revised safety data GC supervised the work. All the authors read and approved the final version. Not applicable. Data supporting the considerations reported in the text can be found at Dr. Bozzola's repository. Ethics approval and consent to participate Not applicable. Not applicable. Not applicable.Received: 5 January 2022 Accepted: 24 February 2022